Attached files
| file | filename |
|---|---|
| EX-31.2 - SECTION 302 CERTIFICATION - GILEAD SCIENCES INC | gild2020form10-kexhibit312.htm |
| EX-31.1 - SECTION 302 CERTIFICATION - GILEAD SCIENCES INC | gild2020form10-kexhibit311.htm |
| EX-23.1 - EXHIBIT 23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - GILEAD SCIENCES INC | gild2020form10-kexhibit231.htm |
| EX-21.1 - EXHIBIT 21.1 LISTING OF SUBSIDIARIES - GILEAD SCIENCES INC | gild2020form10-kexhibit211.htm |
| EX-10.2 - 2004 EQUITY INCENTIVE PLAN AMENDMENT NO. 1 (AMENDED AND RESTATED MAY 10, 2017) - GILEAD SCIENCES INC | gild20ormex102amendmentto2.htm |
| 10-K - FORM 10-K - GILEAD SCIENCES INC | gild-20201231.htm |
Exhibit 32
CERTIFICATIONS
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350, as adopted), Daniel P. O’Day, the Chairman and Chief Executive Officer of Gilead Sciences, Inc. (the Company), and Andrew D. Dickinson, the Chief Financial Officer of the Company, each hereby certifies that, to the best of his or her knowledge:
1. The Company’s Annual Report on Form 10-K for the annual period ended December 31, 2020 (the Report) fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: February 25, 2021
| /s/ DANIEL P. O’DAY | /s/ ANDREW D. DICKINSON | |||||||
| Daniel P. O’Day Chairman and Chief Executive Officer | Andrew D. Dickinson Chief Financial Officer | |||||||
This certification accompanies the Form 10-K to which it relates, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.